Thinking About Addiction
A blog about anything related to addiction, treatment, or recovery, all the way from prevention to building recovery-friendly communities. We also welcome guest bloggers here!
…optimally, the goal isn’t just to get different specialists to work together, it’s to educate all practitioners to address the patient with awareness of both perspectives.
The research team examined 24 years of cases and concluded the impairment was attributable to opioids.
I think the problem is I have read the research, and it didn’t confirm the claims made on its behalf.
I recall several cases admitted to the inpatient psych ward at one hospital where I worked in Boston, usually with severe psychotic symptoms.
Now, with legalization, “cannabusiness” is being commercialized along the lines of alcohol and tobacco.
Investors naturally seek to increase the value of their investment, while patients seek access to medication they need at a price they can afford.
Though recent headlines insist that vaping is almost twice as effective than alternatives, that doesn’t mean it’s especially effective.
I can imagine a hundred scenarios in which Dsuvia somehow leaves the battlefield and finds it way into the world of drug abuse.
The increased incidence of depression, anxiety, and other psychiatric symptoms linked to OUD may also help to account for high rates of relapse among patients, post-treatment, versus other substance disorders.